News | April 24, 2023
Tissue engineered skin substitutes market to reach $3 billion by 2033, forecasts GlobalData
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Fully equipped labs with 75-member team set-up and made operational in <100 days
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
SÜDPACK is setting standards in terms of both performance and sustainability
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Subscribe To Our Newsletter & Stay Updated
